Previous research has indicated habitual consumption of non-caloric artificial sweeteners is associated with increased risk of type 2 diabetes, but the underlying mechanisms have not been established.
The ACC has updated its 2016 expert consensus decision pathway for the use of non-statin drugs for the lowering of LDL cholesterol in patients with atherosclerotic cardiovascular disease.
While previous evidence has linked high-density lipoprotein cholesterol concentrations to good cardiovascular health, a recent study has challenged these findings.
In a recent study, researchers investigated the relationship between continued statin therapy and clinical outcomes in patients with perceived adverse reactions.
Researchers evaluated the efficacy of a score measuring cardiometabolic disease in determining the best treatment for overweight or obese patients at risk for type 2 diabetes. To see which patient...
The USPSTF has updated its 2012 recommendations on behavioral counseling to promote a healthful diet and physical activity for cardiovascular disease prevention among adults without obesity who do not have...